Dicer and outcomes in patients with acute myeloid leukemia (AML).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

1. Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis.Oncotarget · 2016
   Pooled it
2. Possible role of human ribonuclease dicer in the regulation of R loops.FEBS open bio · 2025
   Review
3. Analysis of the p53/microRNA Network in Cancer.Advances in experimental medicine and biology · 2022
   Review
4. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.Frontiers in oncology · 2021
   Review
5. Journal of animal science · 2017
   Article
6. Racial Differences in Expression Levels of miRNA Machinery-Related Genes, Dicer, Drosha, DGCR8, and AGO2, in Asian Korean Papillary Thyroid Carcinoma and Comparative Validation Using the Cancer Genome Atlas.International journal of genomics · 2017
   Article
7. Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.Human pathology · 2016
   Article
8. DICER1: mutations, microRNAs and mechanisms.Nature reviews. Cancer · 2014
   Review
9. Complexity in regulation of microRNA machinery components in invasive breast carcinoma.Pathology oncology research : POR · 2014
   Article
10. MicroRNA Machinery Genes as Novel Biomarkers for Cancer.Frontiers in oncology · 2014
    Review
11. Clinicopathological and prognostic significance of the microRNA processing enzyme DICER1 mRNA expression in colorectal cancer patients.Molecular and clinical oncology · 2013
    Article
12. TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.Blood · 2013
    Article
13. Stop the dicing in hematopoiesis: what have we learned?Cell cycle (Georgetown, Tex.) · 2012
    Article
14. Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia.Cancer science · 2012
    Article
15. Down-regulation of Dicer in hepatocellular carcinoma.Medical oncology (Northwood, London, England) · 2011
    Article
16. DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.Cancer · 2011
    Article
17. Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients.Haematologica · 2011
    Article

Corrections and comments

• Comment on
  Dicer, Drosha, and outcomes in patients with ovarian cancer.2008

Authors and funding

3 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as